Any way you look at it, last week was a big relief. After a grinding six weeks of almost consistent selling, the market finally seemed to catch a legitimate bid and bounce back. The good thing for growth stock investors looking for ideas is that the relentless selling that started when 2016 did has taken some outstanding growth stocks and reset the prices at very attractive entry points.
The latest “Picturing this Week’s Opportunities” research piece from the talented crew at Jefferies spotlights some outstanding growth ideas, highlighted by a tech stock that could have huge upside for patient aggressive growth investors. We screened the list and found three that looked especially timely, all of which are rated Buy.
This company could have a revenue explosion over the next three years if Jefferies is right. Acadia Healthcare Company Inc. (NASDAQ: ACHC) is a provider of inpatient behavioral health services. It operates a network of 226 behavioral health facilities with approximately 9,200 beds in 37 states, Puerto Rico and the United Kingdom. Acadia provides psychiatric and chemical dependency services to its patients in a variety of settings, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs.
The company posted stellar earnings last year, and Jefferies thinks that its revenues can double in three years, owing to not only strong organic growth, but potential acquisitions. Also cited in the past was that political support for expand Medicaid coverage for adult mental health is something that the firm believes could grow the company’s addressable market by up to 30%.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.